Episode Details
Back to Episodes
Episode 218 - JD Finley & Mitch Jones - Palisade Bio
Published 1 month, 1 week ago
Description
On this episode we're joined by Palisade Bio's CEO & CMO, JD Finley & Mitch Jones.
In Q2 2026, Palisade released promising ph1 data for their lead asset - PALI2108 - a PDE4 inhibitor. With recent IND clearance for their ph2 ASCENTRA-UC study, we discuss that data, and what real success looks like clinically & commercially for the business & asset moving forward, in an increasingly busy IBD market.
We hope you enjoy the episode.